Aurinia Pharmaceuticals Inc. reports

Company location: Edmonton, Alberta, Canada
Fiscal year end: 31 December

Aurinia Pharmaceuticals Inc. has filed 612 SEC EDGAR filings since 28 Feb 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
40-F
6-K

SEC filing history

Showing 576-600 of 612 matching filings.

Per page

Current page

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 17 Sep 2015
Reporting date: 17 Sep 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

F-X File 333-206994

F-X

Filing date: 17 Sep 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

F-10 File 333-206994

REGISTRATION STATEMENT ON FORM F-10

Filing date: 17 Sep 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 02 Sep 2015
Reporting date: 02 Sep 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 11 Aug 2015
Reporting date: 11 Aug 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

FORM 6-K

Filing date: 11 Aug 2015
Reporting date: 11 Aug 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 06 Aug 2015
Reporting date: 06 Aug 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 28 May 2015
Reporting date: 27 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 19 May 2015
Reporting date: 19 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

FORM 6-K

Filing date: 15 May 2015
Reporting date: 15 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

40-F/A File 001-36421

AMENDMENT NO. 1 TO FORM 40-F

Filing date: 15 May 2015
Reporting date: 31 Dec 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 15 May 2015
Reporting date: 15 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

6-K

Filing date: 30 Apr 2015
Reporting date: 30 Apr 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 23 Apr 2015
Reporting date: 23 Apr 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 31 Mar 2015
Reporting date: 30 Mar 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

40-F File 001-36421

FORM 40-F

Filing date: 30 Mar 2015
Reporting date: 31 Dec 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-88628

SC 13G

Filing date: 25 Mar 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 09 Mar 2015
Reporting date: 06 Mar 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 27 Feb 2015
Reporting date: 26 Feb 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-88628

SC 13G

Filing date: 17 Feb 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-88628